Patent Portfolio
Throughout his career, Robert G. Khachatryan has developed patented technologies and inventions spanning medicine, biotechnology, cancer research, food technologies, and applied industrial innovation.
His patent portfolio reflects a multidisciplinary approach that combines scientific research, clinical experience, and practical technological development. These innovations address challenges across healthcare, biotechnology, manufacturing, and other applied fields.
Selected examples include:
Anti-Cancer Immune-Modulating Agent (EP1970381B1)
European patent directed toward cancer immunotherapy based on embryonic and tumor-associated antigens and immune system activation. This work formed the scientific foundation for subsequent oncology research programs and later development of synthetic antigen platforms.
Synthetic Cancer Vaccine Platform (Patent Pending - U.S. Provisional Application Filed)
Patent-pending biotechnology platform focused on the generation of defined tumor-associated antigens through recombinant and synthetic approaches. The project represents the current direction of research and development in cancer immunology and translational oncology.
Method for Increasing Human Lifespan and Correcting Age-Related Immune Changes (AM739Y)
Armenian patent directed toward immune system rejuvenation and healthy aging strategies through correction of age-related immunological changes. The invention combines immunomodulatory and endocrine approaches aimed at supporting longevity research and gerontology.
Bank of Autochthonous Strains of Microorganisms (US 6,428,783)
U.S. patent describing personalized microbiome preservation and restoration technologies based on an individual's native intestinal microflora. The invention explored long-term microbial banking and biological approaches to restoration of intestinal microbiocenosis.
Method of Treatment of Human Immunodeficiency Diseases (US 7,090,839)
U.S. patent focused on immune restoration strategies and therapeutic approaches for human immunodeficiency disorders, reflecting broader research interests in immunology and biological regulation.
Lactic Acid Bacteria and Functional Food Products (US 6,368,641)
Biotechnology patent involving probiotic microorganisms and functional food systems based on lactic acid bacteria and soy-derived substrates. The technology explored the intersection of nutrition, microbiology, and health-supporting biological systems.
Medical Diagnostic and Surgical Technologies (SU1688844, SU1694110)
Patented medical technologies focused on physiological monitoring and surgical diagnostics. These inventions introduced objective methods for assessing anesthesia adequacy and tissue viability, supporting clinical decision-making and improving intraoperative evaluation of patient status.
The broader patent portfolio includes additional innovations in biotechnology, food technologies, industrial microbiology, engineering solutions, and applied technological development, reflecting a multidisciplinary approach to research and innovation across several decades.